author-photo

Hiroaki Ikeda

Mie University
Nagasaki University
Hokkaido University

109

Papers

2751

Citations

Citation Trend

Filter By

Papers (72) Sort By

Journal Conference Others

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

2020 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (14)
Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein

2020 Vaccine
Show All
- Source
- Cite
- Save
Citations (4)
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours

2020 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (10)
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.

2020 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (0)
CD4(+) T cells support polyfunctionality of cytotoxic CD8(+) T cells with memory potential in immunological control of tumor.

2020 Cancer Science
Show All
- Source
- Cite
- Save
Citations (7)
Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
[Adoptive therapy with TCR gene-modified T cells for hematological malignancies and solid tumors].

2019 The Japanese journal of clinical hematology
- Hiroaki Ikeda
Show All
- Source
- Cite
- Save
Citations (0)
Novel Cellular Immunotherapy Using Allogeneic Vγ9/δ2-T Cells Gene-Modified to Express HTLV-1 P40Tax-Specific TCR for the Treatment of Adult T Cell Leukemia

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
First-in-human phase I clinical trial of NY-ESO-1 protein cancer vaccine with a novel adjuvant MIS416, NOD2 and TLR9 stimulant, for patients with NY-ESO-1 expressing solid tumors.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination

2018 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (1)